‘Product differentiation and non-linear pricing: strategies for growth in the UK pharmaceutical market’

The CCP seminar series continues on Friday 5th December, with pharma maestro Farasat Bokhari (CCP and ECO) presenting his research on ‘Product differentiation and non-linear pricing: strategies for growth in the UK pharmaceutical market‘. Farasat is an Associate Professor in the School of Economics and specialises in health economics, with a background in applied microeconomics and industrial organisation. An abstract for his paper can be found below.


This paper develops a stylized model to specify conditions for menu pricing and product differentiation as profitable strategies in a monopoly or duopoly market structure. We then empirically compare the effect of these strategies within the growth of firm literature. To this end, we use a quarterly panel dataset on the UK pharmaceutical market for the period Q2 2003 – Q1 2013 to estimate the impact of new product forms and package varieties on business unit. Using a dynamic lag-adjustment model as econometric framework, findings from this study suggest that a new product form leads to 18% growth in the long run, while a new package variety leads to 7% growth. Furthermore, in terms of growth, small and midsize firms benefit from these introductions far more than the larger firms.

The seminar takes place from 13:00-14:00 in the Thomas Paine Study Centre, Room 1.03.

About CCP
The Centre for Competition Policy (CCP) conducts interdisciplinary research into competition policy and regulation.

What do you think?

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: